Changes in Intrapersonal Factors of Participants in the Pregnancy Remote Monitoring Study Who Are at Risk for Pregnancy-Induced Hypertension: Descriptive Quantitative Study

被引:1
|
作者
Lanssens, Dorien [1 ,2 ,3 ]
Vandenberk, Thijs [1 ]
Storms, Valerie [1 ]
Thijs, Inge [1 ]
Grieten, Lars [1 ]
Bamelis, Lotte [4 ]
Gyselaers, Wilfried [1 ,2 ,3 ]
Tang, Eileen [5 ]
Luyten, Patrick [5 ,6 ,7 ]
机构
[1] Hasselt Univ, Fac Med & Life Sci, Limburg Clin Res Ctr, Mobile Hlth Unit, Martelarenlaan 42, B-3500 Hasselt, Belgium
[2] Ziekenhuis Oost Limburg, Dept Obstet & Gynaecol, Genk, Belgium
[3] Hasselt Univ, Fac Med & Life Sci, Dept Physiol, Diepenbeek, Belgium
[4] Ziekenhuis Oost Liburg, Ctr Translat Psychol Res TRACE, Genk, Belgium
[5] KULeuven, Fac Psychol & Educ Sci, Leuven, Belgium
[6] Vrije Univ Brussel, Fac Psychol & Educ Sci, Brussels, Belgium
[7] UCL, Res Dept Clin, Educ & Hlth Psychol, London, England
关键词
intrapersonal factors; peripartum period; pregnancy; pregnancy-induced hypertension; remote monitoring; GENERALIZED ANXIETY DISORDER; POSTNATAL DEPRESSION SCALE; PERINATAL ANXIETY; ANTENATAL ANXIETY; WOMEN; PREVALENCE; SEVERITY; VALIDITY; COMPLICATIONS; VALIDATION;
D O I
10.2196/42686
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The peripartum period, defined as the period from the beginning of the gestation until 1 year after the delivery, has long been shown to be potentially associated with increased levels of stress and anxiety with regard to one's transition to the status of parent and the accompanying parental tasks. Yet, no research to date has investigated changes in intrapersonal factors during the peripartum period in women at risk for pregnancy-induced hypertension (PIH). Objective: The aim of this study is to explore and describe changes in intrapersonal factors in participants at risk for PIH. Methods: We used an explorative design in which 3 questionnaires were sent by email to 110 participants the day following enrollment in the Pregnancy Remote Monitoring program for pregnant women at risk for PIH. Women were invited to complete the questionnaires at the beginning of their participation in the Pregnancy Remote Monitoring project (mostly at 14 weeks of gestation) and after approaching 32 weeks of gestational age (GA). The Generalized Anxiety Disorder-7 Scale (GAD-7) and the Patient Health Questionnaire-9 were used to assess anxiety and depression, and adaptation of the Pain Catastrophizing Scale was used to measure trait pain catastrophizing. Results: Scores were significantly higher at 32 weeks of GA than at the moment of enrollment (GAD-7 score=7, range 4-11 vs 5, range 3-8; P=.01; and Patient Health Questionnaire-9 score=6, range 4-10 vs 4, range 2-7; P<.001). The subscale scores of the Pain Catastrophizing Scale were all lower at 32 weeks of GA compared with 14 weeks of GA (rumination: 4, range 1-6 vs 5, range 2-9.5; P=.11; magnification: 3, range 1-5.5 vs 4, range 3-7; P=.04; and helplessness: 5, range 2-9 vs 6, range 3.5-12; P=.06). The proportion of women with a risk for depression (GAD-7 score >10) was 13.3% (10/75) at enrollment and had increased to 35.6% (26/75) at 32 weeks of GA. Conclusions: This study shows that pregnant women at risk for PIH have higher levels of stress and anxiety at 32 weeks of GA than at the moment of enrollment. Further research is recommended to investigate potential strategies to help pregnant women at risk for PIH manage feelings of stress and anxiety.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Polycystic ovary disease and the risk of pregnancy-induced hypertension
    Kashyap, S
    Claman, P
    JOURNAL OF REPRODUCTIVE MEDICINE, 2000, 45 (12) : 991 - 994
  • [32] The genetic risk factors for pregnancy-induced hypertension: Evidence from genetic polymorphisms
    Wei, Wenwen
    Wang, Xin
    Zhou, Yuanzhong
    Shang, Xuejun
    Yu, Hongsong
    FASEB JOURNAL, 2022, 36 (07)
  • [33] Blood Pressure and Angiogenic Markers in Pregnancy Contributors to Pregnancy-Induced Hypertension and Offspring Cardiovascular Risk
    Birukov, Anna
    Herse, Florian
    Nielsen, Julie H.
    Kyhl, Henriette B.
    Golic, Michaela
    Kraeker, Kristin
    Haase, Nadine
    Busjahn, Andreas
    Bruun, Signe
    Jensen, Boye L.
    Mueller, Dominik N.
    Jensen, Tina Kold
    Christesen, Henrik T.
    Andersen, Marianne Skovsager
    Jorgensen, Jan Stener
    Dechend, Ralf
    Andersen, Louise Bjorkholt
    HYPERTENSION, 2020, 76 (03) : 901 - 909
  • [34] Prevalence of Pregnancy-Induced Hypertension and Its High-Risk Factors among the Antenatal Women
    John, Sony
    Vanitha, M.
    Babu, Athira
    Sushma, Priya
    Regina, Ashihrii Eloni
    Frank, Reena Wilma
    JOURNAL OF HEALTH AND ALLIED SCIENCES NU, 2021, 11 (03): : 154 - 157
  • [35] Oocyte Donation: A Risk Factor for Pregnancy-Induced Hypertension
    Pecks, Ulrich
    Maass, Nicolai
    Neulen, Joseph
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2011, 108 (03): : 23 - U23
  • [36] PREGNANCY-INDUCED HYPERTENSION IS ASSOCIATED WITH CHANGES IN MATERNAL AND UMBILICAL BLOOD ANTIOXIDANTS
    UOTILA, J
    TUIMALA, R
    PYYKKO, K
    AHOTUPA, M
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1993, 36 (03) : 153 - 157
  • [37] Pregnancy-induced hypertension in women who were born small
    Rasmussen, Svein
    Irgens, Lorentz M.
    HYPERTENSION, 2007, 49 (04) : 806 - 812
  • [38] Risk factors associated with gestational diabetes mellitus: The role of pregnancy-induced hypertension and physical inactivity
    Aburezq, Maryam
    AlAlban, Fatima
    Alabdulrazzaq, Maryam
    Badr, Hanan
    PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2020, 22 : 64 - 70
  • [39] Pregnancy-induced hypertension is associated with an increase in the prevalence of cardiovascular disease risk factors in Japanese women
    Watanabe, Kazushi
    Kimura, Chiharu
    Iwasaki, Ai
    Mori, Toshitaka
    Matsushita, Hiroshi
    Shinohara, Koichi
    Wakatsuki, Akihiko
    Gosho, Masahiko
    Miyano, Ichiro
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (06): : 656 - 659
  • [40] A LONGITUDINAL-STUDY OF MATERNAL DIGOXIN-LIKE IMMUNOREACTIVE SUBSTANCES IN NORMOTENSIVE PREGNANCY AND PREGNANCY-INDUCED HYPERTENSION
    KERKEZ, SA
    POSTON, L
    WOLFE, CD
    QUARTERO, HW
    CARABELLI, P
    PETRUCKEVITCH, A
    HILTON, PJ
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 162 (03) : 783 - 787